找回密碼
 To register

QQ登錄

只需一步，快速開始

掃一掃，訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology; Scientific and Clini Mohammad Resa Nowrousian Book 2008Latest edition Spring

[復制鏈接]
查看: 14660|回復: 63
樓主
發(fā)表于 2025-3-21 18:09:38 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
副標題Scientific and Clini
編輯Mohammad Resa Nowrousian
視頻videohttp://file.papertrans.cn/825/824096/824096.mp4
概述Comprehensive presentation of anemia in cancer and its treatment.Assessment of current and potential applications of erythropoietin.Presented by world experts in the field.Includes supplementary mater
圖書封面Titlebook: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology; Scientific and Clini Mohammad Resa Nowrousian Book 2008Latest edition Spring
描述Anemia is a frequent complication of cancer and its treatment. It produces many symptoms and significantly impairs metabolic and physiologic functions as well as patients‘ activity, well-being and quality of life. Life expectancy is also affected. This book, now being published in its second edition, comprehensively presents the current knowledge on anemia in cancer and its treatment with rhEPO. Future developments are also discussed. Based on updated and new chapters, including a broader spectrum of topics, outstanding international experts describe the scientific and clinical aspects of anemia in various fields of oncology and give diagnostic and therapeutic recommendations on when and how to use rhEPO. The book, considered as a standard work, will again serve as an essential source of information for radiotherapists, medical oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion and laboratory medicine, and pharmacologists.
出版日期Book 2008Latest edition
關鍵詞Fatigue; Tumor; anemia; chemotherapy; classification; hemoglobin; pathophysiology; physiology; radiation onc
版次2
doihttps://doi.org/10.1007/978-3-211-69459-6
isbn_softcover978-3-7091-1904-4
isbn_ebook978-3-211-69459-6
copyrightSpringer-Verlag Vienna 2008
The information of publication is updating

書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology影響因子(影響力)




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology影響因子(影響力)學科排名




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology網(wǎng)絡公開度




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology網(wǎng)絡公開度學科排名




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology被引頻次




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology被引頻次學科排名




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology年度引用




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology年度引用學科排名




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology讀者反饋




書目名稱Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics
 

0票 0.00%

Better Implies Difficulty
 

1票 100.00%

Good and Satisfactory
 

0票 0.00%

Adverse Performance
 

0票 0.00%

Disdainful Garbage
您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:12:59 | 只看該作者
The role of erythropoietin receptor expression on tumor cells,a, such as the cancer associated anemia. Anemia is common in patients with malignant disease (.; .). It is either due to the myelosuppressive effects of chemotherapy and/or radiotherapy or sometimes infiltration of the bone marrow. In many cases, cancer patients suffer from the anemia of chronic dis
板凳
發(fā)表于 2025-3-22 02:38:50 | 只看該作者
地板
發(fā)表于 2025-3-22 05:26:15 | 只看該作者
Definition, classification and characterization of anemia in cancer,aditionally used in the physical diagnosis of anemia are pallor of the conjunctivae, nail beds, face, palms, and palmar creases. Among these, only pallor of the conjunctivae, nail beds, and palms can be used in patients of any race. There is evidence suggesting that conjunctival pallor may be more s
5#
發(fā)表于 2025-3-22 08:52:36 | 只看該作者
6#
發(fā)表于 2025-3-22 13:48:07 | 只看該作者
7#
發(fā)表于 2025-3-22 17:32:30 | 只看該作者
Significance of anemia in cancer chemotherapy,and incidence of anemia depend on one side on the type and stage of malignancy and on the other side on the type, schedule and intensity of treatment. Hematological malignancies, particularly myeloid disorders, are generally more often associated with anemia than solid tumors but, depending on the t
8#
發(fā)表于 2025-3-22 22:46:16 | 只看該作者
9#
發(fā)表于 2025-3-23 01:36:39 | 只看該作者
Tumor hypoxia and therapeutic resistance,e to the lack of methods suitable for the routine measurement of intratumoral oxygen tensions in patients. In the late 1980s, a novel and clinically applicable standardized procedure was established enabling the determination of tumor oxygenation in accessible primary tumors, local recurrences, and
10#
發(fā)表于 2025-3-23 05:58:16 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 22:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
班玛县| 万源市| 米脂县| 甘德县| 玉林市| 河池市| 徐水县| 富川| 扶风县| 河津市| 芦溪县| 建昌县| 洪雅县| 平顺县| 聊城市| 聂荣县| 温泉县| 湟中县| 周口市| 郎溪县| 许昌县| 江北区| 夹江县| 黄冈市| 深州市| 新河县| 道真| 陇西县| 隆化县| 皮山县| 安丘市| 民和| 察雅县| 泗洪县| 手游| 米易县| 盘锦市| 宝鸡市| 陇川县| 宣城市| 福鼎市|